These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18405371)

  • 1. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
    Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
    BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Circulating Serum Levels of sCD95 and TNF-α in Cytoprotection of Cervical Cancer.
    Agnihotri SK; Kumar B; Jain A; Anjali A; Negi MPS; Sachan R; Bhatt MLB; Tripathi RK; Sachdev M
    Rep Biochem Mol Biol; 2022 Jan; 10(4):711-721. PubMed ID: 35291617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble forms of CD95 and CD95 ligand after living related liver transplantation.
    Seino K; Kayagaki N; Yamaguchi N; Takada Y; Uyama S; Kiuchi T; Tanaka K; Yagita H; Okumura K; Fukao K
    Transplantation; 1999 Feb; 67(4):634-6. PubMed ID: 10071041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status.
    Jiang JD; Schlesinger M; Sacks H; Mildvan D; Roboz JP; Bekesi JG
    J Clin Immunol; 1997 Mar; 17(2):185-92. PubMed ID: 9083895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners.
    Hoffmeyer F; Henry J; Borowitzki G; Merget R; Bünger J; Brüning T; Raulf-Heimsoth M
    Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):60-3. PubMed ID: 21147622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
    Munker R; Younes A; Cabanillas F; Andreeff M
    Leuk Lymphoma; 1997 Nov; 27(5-6):517-21. PubMed ID: 9477134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.
    Sellner J; Greeve I; Findling O; Grandgirard D; Leib SL; Mattle HP
    Clin Exp Immunol; 2008 May; 152(2):280-4. PubMed ID: 18341614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95-mediated apoptosis and DNA fragmentation in MS.
    Heesen C; Georghiu S; Gbadamosi J; Schoser BG
    Acta Neurol Scand; 2000 Nov; 102(5):333-6. PubMed ID: 11083512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer.
    Zhou JH; Chen HZ; Ye F; Lu WG; Xie X
    Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
    Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
    Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
    Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
    Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation.
    Wang YL; Zhang YY; Li G; Tang ZQ; Zhou YL; Zhu ZJ; Yao Z
    World J Gastroenterol; 2005 Mar; 11(11):1700-4. PubMed ID: 15786554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes.
    Munker R; Midis G; Owen-Schaub L; Andreff M
    Leukemia; 1996 Sep; 10(9):1531-3. PubMed ID: 8751476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.
    Ankersmit HJ; Weber T; Auer J; Roth G; Brunner M; Kvas E; Moser B; Spreitzer S; Lassnig E; Maurer E; Hartl P; Wolner E; Boltz-Nitulescu G; Eber B
    Heart; 2004 Feb; 90(2):151-4. PubMed ID: 14729783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Differences in the Levels of Oxidative Status Marker and Soluble CD95 in Patients with Moderate to Severe COPD during an Exacerbation and a Stable Period.
    Soodaeva S; Kubysheva N; Klimanov I; Shutov A; Eliseeva T; Novikov V; Kontorshchikova K; Novikov D; Batyrshin I
    Oxid Med Cell Longev; 2021; 2021():2105406. PubMed ID: 34925689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of systemic inflammatory response in the carcinogenic process of uterine cervical neoplasia.
    Lages EL; Belo AV; Andrade SP; Rocha MÂ; de Freitas GF; Lamaita RM; Traiman P; Silva-Filho AL
    Biomed Pharmacother; 2011 Oct; 65(7):496-9. PubMed ID: 22004597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in lipid peroxidation and antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer.
    Kim SY; Kim JW; Ko YS; Koo JE; Chung HY; Lee-Kim YC
    Nutr Cancer; 2003; 47(2):126-30. PubMed ID: 15087263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism.
    Ibrahim R; Frederickson H; Parr A; Ward Y; Moncur J; Khleif SN
    Cancer; 2006 Mar; 106(5):1065-77. PubMed ID: 16456813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
    Reesink-Peters N; Hougardy BM; van den Heuvel FA; Ten Hoor KA; Hollema H; Boezen HM; de Vries EG; de Jong S; van der Zee AG
    Gynecol Oncol; 2005 Mar; 96(3):705-13. PubMed ID: 15721415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
    Liu P; Xin F; Ma CF
    Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.